$60.30

0.32 (0.53%)

11/6/2009 4:00 PM

Johnson & Johnson (JNJ)

CAPS Rating:

Engaged in the research and development, manufacture and sale of a range of products in the health care field in many countries of the world.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating JNJ

Add Stock to Watchlist

What the Community Thinks

Total Members

12039 Outperforms

415 Underperforms

All-Stars

2970 Outperforms

56 Underperforms

Wall Street

30 Outperforms

1 Underperforms

Members bullish on JNJ are also bullish on:

Members bearish on JNJ are also bearish on:

Ticker Tags

New Brunswick (1), Blue Chip (121), Mega Cap (113), Medical Device (38), New Jersey (6), Healthcare (737), Big Pharma (10), S&P 500 (500), Dow (29), Pharmaceuticals (153), Income (1520), Top Brands 2006 (59), Defensive (1498), Diversified Conglomerate (16), Buffett Stock (45), Top Brands 2005 (58), Growth (1896), Dividend (191), Multinational Company (15), Behemoth (31)
Suggest a tag

Johnson & Johnson At A Glance

Current Price:	$60.30
Last Trade Time:	11/6/2009 4:00 PM
Open:	$59.94
Previous Close:	$59.98
Daily Range:	$59.57 - $60.34
52-Week Range:	$46.25 - $63.01
Volume:	8,503,051
Market Cap:	$166.18B
P/E Ratio:	12.98
Compare Our Special Broker Offers!

Stock Trends

JNJ VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for JNJ

Final Glance: Pharmaceuticals companies
11/6/2009 5:55:45 PM -
Final Glance: Medical Devices companies
11/6/2009 5:55:44 PM -
The Weekly Layoff Report: A Busy Week
11/6/2009 5:25:00 PM -
Boston Scientific to Settle DOJ Defibrillator Case
11/6/2009 3:15:00 PM -

More Headlines...

Top Bull Pitch

Recs

22 Johnson & Johnson (JNJ)

Avatar poppycock2 (63.40) Submitted: 8/24/09 3:37 PM

Been around many years, solid management, plenty of cash to buy Biotech companies with promising drugs, sell things people actually need and use, pays a solid dividend which over time will help you build wealth

Replies: 4 | Reply | Permalink

Top Bear Pitch

Recs

1 Johnson & Johnson (JNJ)

Avatar Alleymae (< 20) Submitted: 6/19/08 11:57 AM

Believe that republicians will regain control of the white house and congress, making the economy even tighter, which should reduce the sizes of households, JNJ services mostly households, causing a drop.

Replies: 3 | Reply | Permalink

CAPS Members

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 1983 : 1 2 3 4 5 Next » Jump to page:

Recs 0 (JNJ) Jim2B (57.96) Submitted: 11/06/09 3:55 PM : Start Price: $60.01 JNJ Score: 16.17 Overall based upon accelerating (home & business) foreclosures, financial weakness in the banking sector, tremendous tax increases on the horizon (suppressing the economy), and a federal spending policy that can only result in double digit inflation, I expect the economy (& stock prices) to decline over the remainder of 2009 and through 2010 at the least. So the question is not whether JNJ goes up or down but by how it does in relation to the S&P500. JNJ's sterling financial strength and proven management team provides it a great deal of protection against possible declines in the economy. In fact any company with strong financials should perform better than the market average in a down economy. Now with the prospect of a government run health care bill raising punitive taxes upon any company in that sector, expect the price to remain depressed until everything sorts out. Still given the fact that JNJ has a lot of non-health care related business over which it can distribute those taxes, it should not be as adversely affected as say PFE or MRK. So I expect the stock price to remain depressed over the short term (giving you time to buy the stock) with a nice bump if Congress fails to pass something before the end of the year. In the mid-term, conservative management, good management, and good financial strength will preserve stock price values better than other S&P500 companies. In the long-term expect JNJ stock prices to rise when the economy improves in line with other companies. Overall, I'd say that JNJ is a safe bet with reasonable upside and limited downside. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (JNJ) 3dollarhedgefund (34.83) Submitted: 11/06/09 2:22 PM : Start Price: $60.20 JNJ Score: -0.04 Health care stocks have been punished by uncertainty during the debate over the future of health care in the United States, and while Johnson and Johnson's valuation is not currently compelling, it is reasonable at 13 times earnings, paying slightly better than a 3% yield. Unlike pharmaceutical behemoths like Merck, Johnson and Johnson is at least as much a consumer goods stock as a pharma stock: its products include shampoo, Band-Aids, and other goods which consumers will continue to purchase even when their disposable income is limited. J&J derives a substantial portion of its revenue from overseas, and also engages in currency hedging, giving some protection from a steep decline in the US dollar relative to other currencies. We follow this company and some other fine businesses on our blog at http://threedollarhedgefund.blogspot.com. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (JNJ) rainmaker59 (50.65) Submitted: 11/06/09 2:11 PM : Start Price: $60.30 JNJ Score: -0.19 Steady giant, paying dividends, that has low P/E. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (JNJ) PhilLabrasca (60.59) Submitted: 11/04/09 4:55 PM : Start Price: $59.81 JNJ Score: -0.57 I am confident in their management, products, r&d, balance sheet, market share, and their future. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (JNJ) cougarVF61 (36.61) Submitted: 11/02/09 8:22 PM : Start Price: $60.04 JNJ Score: -2.83 no brainer,good products, good mgmt Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 1983 : 1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 31 of 31

picks per page. CHANGE Expand All Pitches Collapse All Pitches

Top Pick	Member Name	Member Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackJimCramer	< 20	10/15/09		3W	$60.94	-1.05%	-2.35%	-1.30
	TrackStandpoint	95.65	04/29/09		NS	$50.09	+20.38%	+22.99%	-2.61
	TrackWachovia	35.10	04/20/09		NS	$52.28	+15.33%	+26.54%	-11.21
	TrackUBS	86.41	03/20/09		NS	$50.24	+20.03%	+37.44%	-17.41
	TrackFortune2009	52.16	12/11/08		1Y	$56.81	+6.15%	+25.99%	-19.84
	TrackBobOlstein	50.29	06/18/08		5Y	$62.74	-3.89%	-17.42%	+13.53
	TrackGaryBSmith	41.83	02/15/08		3W	$59.64	+1.11%	-17.38%	+18.49
	TrackStanfordRes	80.42	01/23/08		NS	$60.75	-0.74%	-12.77%	+12.04
	TrackHeebner	23.58	12/31/07		NS	$63.24	-4.65%	-23.64%	+18.99
	TrackRichPzena	< 20	09/30/07		NS	$61.91	-2.60%	-26.44%	+23.83
	TrackVanDenBerg	65.31	09/30/07		NS	$61.91	-2.60%	-26.44%	+23.83
	TrackDodgeCox	86.63	09/30/07		NS	$61.91	-2.60%	-26.44%	+23.83
	TrackHillman	91.15	09/30/07		NS	$61.91	-2.60%	-26.44%	+23.83
	TrackJohnRogers	< 20	09/30/07		NS	$61.91	-2.60%	-26.44%	+23.83
	TrackBuffett	75.42	09/30/07		NS	$61.91	-2.60%	-26.44%	+23.83
	TrackBrandes	< 20	09/30/07		NS	$61.91	-2.60%	-26.44%	+23.83
	TrackEdwardOwens	98.26	09/30/07		NS	$61.91	-2.60%	-26.44%	+23.83
	TrackRichAster	91.10	09/30/07		NS	$61.91	-2.60%	-26.44%	+23.83
	TrackBRogers	96.65	09/30/07		NS	$61.91	-2.60%	-26.44%	+23.83
	TrackEveillard	89.92	09/30/07		NS	$61.91	-2.60%	-26.44%	+23.83
	TrackHAndW	23.63	09/30/07		NS	$61.91	-2.60%	-26.44%	+23.83
	TrackMichaelBrus	93.35	08/08/07		1Y	$58.49	+3.09%	-24.37%	+27.47
	TrackPatDorsey	80.29	04/27/07		3Y	$59.68	+1.04%	-24.26%	+25.30
	TrackDeutscheSec	89.50	04/18/07		NS	$59.85	+0.76%	-23.14%	+23.90
	TrackMichaelSivy	90.71	03/20/07		1Y	$55.83	+8.01%	-19.66%	+27.67
	TrackCharlesPayn	35.46	02/24/07		3M	$59.66	+1.07%	-21.74%	+22.81
	TrackKiplinger	60.72	01/03/07		1Y	$61.40	-1.78%	-19.57%	+17.78
	TrackScottBleier	63.76	10/28/06		3M	$63.40	-4.89%	-17.57%	+12.68
	TrackWayneRogers	< 20	10/13/06		3M	$60.06	+0.40%	-16.74%	+17.14
	TrackHilliard	45.54	10/05/06		NS	$60.38	-0.13%	-15.70%	+15.57
	TrackBofASec	93.50	09/05/06		NS	$59.73	+0.95%	-13.16%	+14.11

Results 1 - 31 of 31

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.